Medlive Technology Renews Connected Transactions With M3
Medlive (02192.HK) received shareholding of 0.285 million ordinary shares from Fidelity International and its affiliates, worth approximately 2.5296 million Hong Kong dollars.
On October 23, according to the documents disclosed by the Hong Kong Stock Exchange on October 23, FIL Limited increased its shareholding in Medlive (02192.HK) by an average of 8.8757 Hong Kong dollars per share on October 18, with a total of 0.285 million shares of common stock, worth approximately 2.5296 million Hong Kong dollars. After the increase, FIL Limited's latest number of shares held is 66.237 million shares, and the stake ratio has increased from 8.99% to 9.04%. This trade involves other related parties: Pandanus Associates Inc. and Pandanus.
MEDLIVE: INTERIM REPORT 2024
Medlive Technology Co., Ltd. Just Recorded A 32% EPS Beat: Here's What Analysts Are Forecasting Next
Medlive Technology's Profit Soars 49% in H1
HKEX unusual movement | Medlinker (02192) rose more than 6% after the performance adjustment, with a year-on-year increase of more than 30% in net income and a continued high net profit margin.
After the performance of Medlinker (02192), it rose more than 6%, and as of the time of publication, it rose 6.52%, closing at HKD 8.13, with a turnover of HKD 7.139 million.
Hong Kong stocks surged | iClick Interactive Asia Group (02192) rose more than 6%, with a 48.6% year-on-year increase in net profit in the first half, steadily improving its precision marketing business.
Aidimei (02192) rose more than 6%, as of the deadline for submission, rose 6%, to HK$8.13, with a turnover of HK$6.3692 million.
MEDLIVE To Go Ex-Dividend On October 22nd, 2024 With 0.132 HKD Dividend Per Share
August 28th (Beijing Time) - $MEDLIVE(02192.HK)$ is trading ex-dividend on October 22nd, 2024.Shareholders of record on October 23rd, 2024 will receive 0.132 HKD dividend per share on November 18th, 2
Medlive Technology Declares Interim Dividend
Medlinker (02192) will distribute a mid-term dividend of HKD 0.1205 per share on November 18th.
Airiti Inc. (02192) announced that it will distribute the payment until June 30, 2024, on November 18, 2024.
Medlive Technology Posts Strong Half-Year Growth
YiMaiTong (02192) releases its interim performance results, with adjusted net profit of 0.156 billion yuan, a year-on-year increase of 30.3%.
Medlinker (02192) has released its interim performance for the six months ending June 30, 2024, with the group achieving revenue growth...
The performance of Medlink (02192.HK) increased by 48.6% in the first half of the year, with a net profit of 0.147 billion yuan and a mid-term dividend of 12.05 yuan per share.
Medical Communications (02192.HK) announced its interim performance as of the end of June this year, with revenue of 0.243 billion yuan (RMB) and a year-on-year increase of 40.3%. Net profit was 0.147 billion yuan, up 48.6% year-on-year; earnings per share were 20.18 cents. The interim dividend is 12.05 cents, compared to 10.67 cents in the same period last year.
MEDLIVE: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2024
Medlinker (02192.HK): User activity continues to increase, high growth in precision marketing revenue.
Performance Summary 27th August 2024, the company disclosed its 2024 interim performance: in H1 2024, the company achieved revenue of 0.243 billion yuan, a year-on-year increase of 40.3%; achieved net income attributable to the parent company of 0.147 billion yuan, year-on-year.
Medlinker (2192.HK) 2024 mid-term performance review: performance exceeds expectations, customer and service product numbers continue to grow.
Performance overview: In the first half of 2024, the company achieved revenue of 0.243 billion yuan (+40.3%); net income attributable to shareholders was 0.147 billion yuan (+48.6%); adjusted net income was 0.156 billion yuan (+30.3%). 24H1
Yi Mai Tong (02192.HK) plans to hold a board of directors meeting on August 27th to approve the interim performance.
On August 8th, HealthLink (02192.HK) announced that the board of directors meeting will be held on Tuesday, August 27, 2024 to consider and approve the company's and its subsidiaries' mid-term performance as of June 30, 2024, and consider the distribution of mid-term dividends (if any).
MEDLIVE: DATE OF BOARD MEETING
HK stocks unusual movement | Ping An Healthcare and Technology Co Ltd (02192) rose more than 17% during trading hours recently, reaching a strategic cooperation agreement with NCCN for cancer care.
During trading, Meinian Onehealth (02192) rose more than 17%. At the time of publication, it had risen 10.16%, to HKD 7.59, with a turnover of HKD 11.3699 million.
AIMedical (02192.HK) has achieved a strategic partnership with NCCN for cancer care.
The National Comprehensive Cancer Network (NCCN) and iMedicineHub (02192.HK) announced a strategic partnership to expand accessibility to the well-known Chinese tumor guide, providing key resources for cancer care for Chinese healthcare professionals and patients. As of June of this year, NCCN has over 1.9 million registered users, and China is the second largest country in terms of users, only behind the USA. Cancer-related nursing guidelines are downloaded over 0.85 million times each year, with many users downloading them through the iMedicineHub platform.